FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
Hyunbin KimAndy Jinseok LeeJongkeun LeeHyonho ChunYoung Seok JuDong Wan HongPublished in: Genome medicine (2019)
In summary, FIREVAT facilitates a novel refinement strategy using mutational signatures to distinguish artifactual point mutations called in human cancer samples. We anticipate that FIREVAT results will further contribute to precision oncology efforts that rely on accurate identification of variants, especially in the context of analyzing mutational signatures that bear prognostic and therapeutic significance. FIREVAT is freely available at https://github.com/cgab-ncc/FIREVAT.